Poteligeo
The RxWiki Digital Pharmacist stamp of approval lets you know that this content has been created and reviewed by a licensed pharmacist.
Poteligeo is a cancer medicine used to treat two blood cell cancers that mainly affect the skin, mycosis fungoides and Sezary syndrome. These are rare cancers called cutaneous T-cell lymphomas.
Poteligeo Overview
Poteligeo is a prescription medication used to treat some types of skin lymphoma, a cancer of the white blood cells that starts in the skin. Poteligeo is for adults with mycosis fungoides (MF) or Sezary syndrome (SS) who had previous systemic (whole-body) treatment, and whose cancer didn’t get better, or got better but came back.
Poteligeo belongs to a group of drugs called monoclonal antibodies. It binds to certain cancerous T-cells, triggering your body’s immune cells to specifically target them.
This medication comes in an injectable form to be given directly into a vein (IV) by your doctor or healthcare provider. You may receive seven treatments for the first cycle and then receive two treatments in subsequent cycles; each cycle is 28 days.
Common side effects include rash, tiredness, diarrhea, muscle and bone pain, and upper respiratory tract infection.
How was your experience with ?
Poteligeo Drug Class
Poteligeo is part of the drug class: